Email this article 
Are menses always necessary for pregnancy in patients with breast cancer?
- Authors: Sheremet M.Y.1, Protasova A.E.1,2,3, Turomsha A.N.1
-
Affiliations:
- AVA-PETER LLC
- Saint Petersburg State University
- V.A. Almazov National Medical Research Centre, Ministry of Health of Russia
- Issue: Vol 21, No 3 (2025)
- Pages: 65-67
- Section: MAMMOLOGY. CLINICAL CASE
- Published: 21.11.2025
- URL: https://ojrs.abvpress.ru/ojrs/article/view/1407
- DOI: https://doi.org/10.17650/1994-4098-2025-21-3-65-67
- ID: 1407
Cite item
Full Text
Abstract
A clinical case of pregnancy in a patient with breast cancer during adjuvant hormonal therapy with tamoxifen is presented. The patient underwent combined treatment: neoadjuvant chemotherapy with ovarian suppression, organpreserving surgery, radiation therapy and further hormonal therapy after the cancellation of ovarian suppression. The clinical case emphasizes the need to inform patients about the risk of pregnancy without restoration of menstrual function during tamoxifen intake and the importance of reliable contraception.
About the authors
M. Yu. Sheremet
AVA-PETER LLC
Author for correspondence.
Email: sheremet-my@avaclinic.ru
ORCID iD: 0009-0008-4392-0700
Marina Yuryevna Sheremet
Build. 2, 4 Ilyushina St., Saint Petersburg 196634
Russian FederationA. E. Protasova
AVA-PETER LLC; Saint Petersburg State University; V.A. Almazov National Medical Research Centre, Ministry of Health of Russia
ORCID iD: 0000-0001-7930-8048
Build. 2, 4 Ilyushina St., Saint Petersburg 196634
7–9 Universitetskaya Naberezhnaya, Saint Petersburg 199034
2 Akkuratova St., Saint Petersburg 197341
Russian FederationA. N. Turomsha
AVA-PETER LLC
ORCID iD: 0009-0008-4164-2372
Build. 2, 4 Ilyushina St., Saint Petersburg 196634
Russian FederationReferences
- Gynecology: national guidelines. Eds.: G.M. Savelyeva, G.T. Sukhikh, V.N. Serova et al. 2nd edn., revised. Moscow: GEOTAR-Media, 2020. 1008 p. (In Russ.).
- Partridge A.H., Hughes M.E., Warner E.T. et al. Subtypedependent relationship between young age at diagnosis and breast cancer survival. J Clin Oncol 2016;34:3308–14. doi: 10.1200/JCO.2015.65.8013
- Barthelmes L., Gateley C.A. Tamoxifen and pregnancy. Breast 2004;13:446–51. doi: 10.1016/j.breast.2004.08.007
- Braems G., Denys H., De Wever O. et al. Use of tamoxifen before and during pregnancy. Oncologist 2011;16(11):1547–51. doi: 10.1634/theoncologist.2011-0121
- Jyoti B., Bharat Ch., Ankita N. et al. Pregnancy on tamoxifen: Case-report and review of literature. South Asian J Cancer 2016;5(4):209, 210. doi: 10.4103/2278-330X.195347
- Ives A., Saunders C., Bulsara M. et al. Pregnancy after breast cancer: Population-based study. BMJ 2007;334:194. doi: 10.1136/bmj.39035.667176.55
- Buonomo B., Brunello A., Noli S. et al. Tamoxifen exposure during pregnancy: A Systematic review and three more cases. Breast Care (Basel) 2020;15(2):148–56. doi: 10.1159/000501473
- Tewari K., Bonebrake R.G., Asrat T. et al. Ambiguous genitalia in infant exposed to tamoxifen in utero. Lancet 1997;350:18. doi: 10.1016/S0140-6736(97)24029-8
- Han S.N., Kesic V.I., van Calsteren K. et al. Cancer in pregnancy: A survey of current clinical practice. Eur J Obstet Gynecol Reprod Biol 2013;167(1):18–2. doi: 10.1016/j.ejogrb.2012.10.026
Supplementary files
